Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

No cure exists for alopecia areata, and treatments are personalized.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

Maltadya Tail might be a good, affordable, and easy-to-use treatment for hair loss.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

PRP is effective for treating hair loss in men.

The document discusses hair and nail conditions, updates on treatments for alopecia, and controversies around finasteride use.

The document concludes that there have been significant advances in the treatment and diagnosis of various skin conditions.

Tofacitinib may help regrow hair in alopecia areata patients.

Polycystic Ovarian Syndrome (PCOS) can be effectively treated with Ayurvedic dietary management.

We need better research to improve alopecia treatment and patient care.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Different nail disorders are treated by targeting their specific causes and using appropriate medications or protective measures.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Topical corticosteroids are the best initial treatment for children with Alopecia Areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Researchers developed a method to grow human hair follicles using 3D-printed skin models and modified cells.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Melanoma patients can learn to check their skin, early balding in men may indicate similar risks as PCOS in women, certain criteria can help predict skin cancer behavior, small skin cancer may not need extra therapy after surgery, and sterile gloves don't reduce infection in minor surgeries.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Chrysanthemum zawadskii extract may help treat hair loss by promoting hair growth and affecting growth factors.

Poly-γ-glutamic acid may help reduce hair loss.